Kunte, Sameer A. https://orcid.org/0000-0002-5235-5941
Inoue, Lurdes Y. T.
Abraham, William T.
Cleland, John G. F.
Curtis, Anne B.
Friedman, Daniel J.
Gold, Michael R.
Kutyifa, Valentina
Linde, Cecilia
Tang, Anthony S.
Sanders, Gillian D.
Al-Khatib, Sana M.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (1R01HL131754)
Article History
Received: 2 November 2024
Accepted: 31 March 2025
First Online: 9 April 2025
Declarations
:
: Dr Cleland reports grants and personal fees from Pharmacosmos; personal honoraria from Abbott, Astra Zeneca, Idorsia, Myokardia, NI Medical, Novartis, Servier, and Torrent Pharmaceuticals; grants and personal honoraria from Amgen/Cytokinetics, Bayer, Bristol Myers Squibb, Johnson & Johnson, Medtronic, Vifor, and Viscardia; and personal honoraria and nonfinancial support from Boehringer-Ingelheim outside the submitted work. Dr Curtis serves on medical advisory boards for Janssen Pharmaceuticals, Medtronic, Abbott, Milestone Pharmaceuticals, and Eagle Pharmaceuticals; she has received honoraria for speaking from Abbott and Medtronic. Dr Friedman has received research support from American Heart Association, Boston Scientific, Biosense Webster, Merit Medical, Medtronic, National Institutes of Health, and Abbott and consulting fees from Abbott, AtriCure, Microport, NI Medical, and Sanofi. Dr Gold serves on a medical advisory board for CVRx and EBR; receives research support to his institution from Boston Scientific, Abbott, and Medtronic; and is a consultant to Boston Scientific, Abbott, and Medtronic. Dr Linde has received research support to her institution from Swedish Heart-Lung Foundation, Swedish Academy of Science, Roche Diagnostics, Astra Zeneca, and Stockholm County Council and speaker honoraria from Medtronic, Impulse Dynamics, Bayer, Boeringer Ingelheim, Novartis, Vifor Pharma, and Microport. The remaining authors report no disclosures.